AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, ... RTL to buy Sky Deutschland for €150mn in TV consolidation effort ...

WILMINGTON, DE — Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward in the treatment of hormone receptor (HR)-positive, HER2-negative advanced ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, was safe and tolerable in an early-stage trial, with side effects ...

Drawn up syringes containing the AstraZeneca COVID-19 vaccines and the empty vial are seen in a tray at the Claremont Showgrounds Covid-19 Vaccination Clinic on May 03, 2021 in Perth, Australia.

AstraZeneca’s spokesperson also pointed to AZD6234, a long-acting amylin in a phase 1 trial for obesity that’s due to complete in October. AstraZeneca GLP-1 Diabetes Biotech. Connect.

AstraZeneca is the largest foreign owned pharmaceutical company in China based on revenue, and they’re continuing to increase investment in the country. Newsletters Games Share a News Tip.

AstraZeneca, Tempus and Pathos AI have signed a multi-year agreement to develop a large-scale multimodal deep learning model designed to accelerate cancer drug discovery.

(Reuters) -Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday, seeking to accelerate the development of its cell therapy ...

Pharmaceutical company AstraZeneca plans to acquire biotech company Fusion Pharmaceuticals for up to $2.4 billion, Investopedia reported March 19. The acquisition will cost around $2 billion at ...

AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand. The vaccine — called Vaxzevria and ...